Senior Talent Acquisition Specialist at Abata Therapeutics

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

Bachelor’s degree in human resources, business administration, or a related field
Minimum of 7 years’ progressive experience in talent acquisition or recruitment within the biotechnology or pharmaceutical sector; agency experience is highly valued
Demonstrated expertise in all facets of talent acquisition, including workforce planning, employer branding, and advanced interview techniques
In-depth understanding of the unique practice areas within a growing biotechnology organization
Mastery of Applicant Tracking Systems (ATS), HR databases, and recruitment analytics
Comprehensive knowledge of employment laws, regulations, and compliance standards
Proven success in designing and executing recruitment strategies
Exceptional verbal and written communication skills, with the ability to influence and engage stakeholders at all levels
Track record of success in high-growth, fast-paced environments
Ability to handle sensitive and confidential information with the utmost discretion and professionalism

Responsibilities

Architect and implement recruitment plans to source exceptional candidates for a diverse range of roles, leveraging deep industry knowledge and innovative sourcing techniques
Manage a portfolio of open requisitions, overseeing every aspect of the process: job description development, targeted outreach, rigorous resume screening, advanced interview methodologies (virtual and on-site), candidate and stakeholder communications, offer negotiation, and seamless onboarding
Cultivate and optimize sourcing channels—including social media, professional networks, and specialized job boards—to identify and engage high-caliber talent
Build and maintain strategic relationships with placement agencies, contract recruiters, and external partners, ensuring a consistent and compelling employer brand presence across all recruiting campaigns
Oversee the Applicant Tracking System (ATS), ensuring compliance with Janux and regulatory standards, and deliver actionable insights through robust reporting on hiring trends, turnover, and candidate experience
Champion diversity, equity, and inclusion initiatives throughout the recruitment process, fostering a culture of belonging and innovation
Serve as a trusted advisor to hiring managers and senior leaders, providing market intelligence and guidance on talent strategy
Adapt and thrive in a fast-paced, rapidly evolving environment, continuously seeking opportunities to enhance recruitment processes and outcomes

Skills

Talent Acquisition

Recruitment

Sourcing

ATS

Interviewing

Offer Negotiation

Employer Branding

Diversity Recruiting

Applicant Tracking System

Hiring Analytics

Job Description Writing

Stakeholder Management

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free